Suits Target Endo, Actavis Over Lidoderm Pay-For-Delay
Endo Pharmaceuticals Inc. and Actavis Inc. have been hit with two putative class actions in the past week in Pennsylvania and California federal courts over their patent settlement that allegedly delayed...To view the full article, register now.
Already a subscriber? Click here to view full article